U.S. Bishops’ Secretariat of Pro-Life Activities Calls NIH’s Dr. Francis Collins Defense of Using Baby Body Parts from Abortions for Research “Deeply Disturbing”

December 18, 2018

WASHINGTON—Dr. Francis Collins, director of the National Institutes of Health (NIH), recently defended current NIH research that uses the body parts of babies destroyed by elective abortions and said that fetal tissue research “will continue to be the mainstay.”

Greg Schleppenbach, Associate Director of the U.S. Bishops’ Secretariat of Pro-Life Activities, responds with the following statement:

“Dr. Collins’ comments are deeply disturbing. Research using fetal tissue from aborted babies is unethical and should not continue under his leadership. The use of fetal remains procured from abortions can be interpreted as legitimizing abortion by saying it is an important source for research. It also requires close collaboration with the abortion industry. Every abortion stops a beating heart, unjustly denying a defenseless human being of her or his life. There is nothing pro-life about further violating these aborted babies by scavenging, even commodifying, their body parts for use in research. The remains of aborted babies are human remains and should be given the full respect they deserve. Millions of pro-life Americans find such research morally offensive and do not want their tax dollars to be used to pay for it.

Researchers have demonstrated the ability to both pursue excellence in research and to avoid violating the rights and dignity of nascent human beings. Dr. Collins can and should lead the NIH in a way that honors both ends, incentivizing research that all Americans can support.”

Keywords: United States Conference of Catholic Bishops, USCCB, Secretariat of Pro-Life Activities, Greg Schleppenbach, Dr. Francis Collins, National Institutes of Health (NIH), elective abortions, research, fetal tissue, abortion industry, unethical, commodifying, human remains, tax dollars, pro-life, human life, human dignity, pro-life, human beings


Media Contact:

Judy Keane